KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Other Non-Current Assets (2016 - 2025)

AbbVie (ABBV) has disclosed Other Non-Current Assets for 14 consecutive years, with $10.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 17.27% to $10.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $10.7 billion, a 17.27% increase, with the full-year FY2025 number at $10.7 billion, up 17.27% from a year prior.
  • Other Non-Current Assets was $10.7 billion for Q4 2025 at AbbVie, up from $9.6 billion in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $10.7 billion in Q4 2025 to a low of $4.7 billion in Q3 2021.
  • A 5-year average of $7.1 billion and a median of $6.6 billion in 2023 define the central range for Other Non-Current Assets.
  • Biggest YoY gain for Other Non-Current Assets was 81.65% in 2021; the steepest drop was 0.68% in 2021.
  • AbbVie's Other Non-Current Assets stood at $4.9 billion in 2021, then increased by 14.07% to $5.6 billion in 2022, then soared by 52.81% to $8.5 billion in 2023, then increased by 7.39% to $9.1 billion in 2024, then rose by 17.27% to $10.7 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Other Non-Current Assets are $10.7 billion (Q4 2025), $9.6 billion (Q3 2025), and $9.7 billion (Q2 2025).